Navigation Links
Brain Sentinel Announces Business Partnership with Academy Medical to Bring Breakthrough SPEAC® System Seizure Monitor to Active and Retired Military with Epilepsy
Date:8/1/2017

Brain Sentinel, Inc., manufacturer of the novel SPEAC® System, proudly announces its entrance into the military healthcare market with the launch of its exclusive, federal, distribution partnership with Academy Medical LLC , a certified Service-Disabled Veteran-Owned Small Business. The partnership makes the SPEAC® System, a recently FDA-cleared Seizure Monitoring and Alerting System, available to the Department of Veterans Affairs (VA), Department of Defense (DoD), and Indian Health Services (IHS) medical treatment facilities. The SPEAC® System is the first FDA-cleared, non-EEG, physiological, signal-based system for seizure monitoring.

“The VA has recognized that uncontrolled epilepsy is a problem within the military”, said Mike Girouard, President, CEO and Cofounder of Brain Sentinel, Inc. According to the 2016 Epilepsy Centers of Excellence Annual Report, the VA reported that

  • 83,362 veterans sought care for their epilepsy in 2015, 1.3% of all VA patients
  • The prevalence of epilepsy in the VA population is 13.8 per 1,000 patients
  • 843 patients were admitted for long-term monitoring

Girouard continued, “We are excited to partner with Academy Medical to bring a new diagnostic tool to the VA medical community. Academy is a recognized leader in bringing novel medical technologies to those serving or who have served our country. With the vast majority of epilepsy care delivered in the home, the SPEAC® System is uniquely positioned to help neurologists better help those who have served our country.”

“We are excited about the opportunity to expand our portfolio and offerings into the government channel by affiliating with Brain Sentinel,” said Dan Shaw, President, Academy Medical. “We have been working on this partnership for some time and are looking forward to this long lasting mutually beneficial relationship.”

About the SPEAC® System
On February 16, 2017, Brain Sentinel received US Food and Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. The adjunctive seizure monitoring system is indicated for adults at home or in healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed on the belly of the biceps muscles to analyze surface electromyography (sEMG) signals that may be associated with generalized tonic-clonic (GTC) seizures. It provides an alarm to alert caregivers of unilateral, appendicular, tonic extension that could be associated with a GTC seizure. The System records and stores sEMG data for subsequent review by a trained healthcare professional.

ABPN board-certified epileptologist and Brain Sentinel cofounder José E. Cavazos, MD, PhD, added, ¨There hasn’t been a reliable and easy way to gather accurate and comprehensive seizure data to help guide proper treatment. Physicians rely on patient or eyewitness reports which have been shown to be unreliable. The sEMG biomarker is an exciting breakthrough because it reflects the activity of the primary motor cerebral cortex.” Harnessing the rich sEMG data through recording and in-depth analysis allows patients and their seizures to “speak” to physicians in a way not possible before. Seizure data gaps that existed before can now be addressed with long-term sEMG monitoring that records the time, date, audio, and the length of the tonic and clonic phases of the sEMG events. Most seizures occur during sleep and within the first two hours of wakefulness. 83% of those seizures aren’t documented. The collection of sEMG and audio information during a potential GTC seizure event makes the SPEAC® System a bimodal tool which may help treating physicians improve the diagnostic characterization of the events as well as objectively monitor success in moving patients toward treatment goals.

About Brain Sentinel
Brain Sentinel, Inc. is a privately held medical device start-up based in San Antonio, Texas. The company manufactures and markets its sEMG-based System under the name, the SPEAC® System: the Sensing, Portable sEMG, Analysis and Characterization System. Brain Sentinel is committed to helping people gain better control over their seizures and be heard by their physicians.

About Academy Medical
Academy Medical, LLC is a certified Service-Disabled Veteran-Owned Small Business specializing in providing innovative orthopedic implants, allograft tissue, wound care products and other medical devices. Having established a purchasing relationship with over 130 government facilities worldwide, Academy Medical’s expansive network delivers value through solutions that provide direct access to the multi-million dollar federal medical marketplace.

Read the full story at http://www.prweb.com/releases/2017/07/prweb14550565.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Xulon Press Announces New Book Addressing the Chemical Composition of a Brain Chip
2. Worldwide Clinical Trials Selected by BrainStorm as CRO for Phase 3 NurOwn Trial in ALS
3. Brain State Technologies New Wearable Technology Introduction via Kickstarter Campaign a Major Success
4. Biomarkers in Concussion Management to be Key Topic at Arrowhead Publishers’ 7th Annual Traumatic Brain Injury Conference
5. Brainstorm Cell Therapeutics to Present at ARMs 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston
6. BrainStorm Announces Financial Results for 2016 and Provides Business Update
7. Stem Cell Treatment Has Potential to Help Parkinson’s Disease Unexpected Brain Area
8. Optical Tool Monitors Brain’s Circulatory Response to Pain
9. BrainStorm CEO to Present at the Sachs Associates 2nd Annual Neuroscience Biopartnering and Investment Forum
10. New Optical Nanosensor Improves Brain Mapping Accuracy, Opens Way for Broader Range of Applications
11. FDA Grants de novo Clearance for the Brain Sentinel® Monitoring and Alerting System, Bringing a New Biomarker to Help People With Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2018)... BUFFALO, N.Y. (PRWEB) , ... July 31, 2018 ... ... release of 2 additional CE/IVD marked molecular quality controls to its expanding CE/IVD ... molecular quality controls to our expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed ...
(Date:7/25/2018)... , ... July 25, 2018 , ... ... biofield energy treated proprietary nutraceutical to combat inflammation and autoimmune disorders. , ... immune function response. The following data was reported:, ...
(Date:7/24/2018)... (PRWEB) , ... July 23, 2018 , ... ... of a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and ... immune function response assessed in the preclinical research were significantly reduced. Results are ...
(Date:7/22/2018)... ... 2018 , ... Mitotech S.A, a Luxembourg based clinical stage ... clinical program in Dry Eye Disease. Under the agreement Essex Bio-Investment will fund ... the first Phase 3 study starting as early as Fall 2018. , ...
Breaking Biology Technology:
(Date:8/7/2018)... ... August 06, 2018 , ... Passersby can’t help ... Southern Illinois University Edwardsville’s University Park. SIUE students are working the “Feedstock Diversity ... These three feedstocks represent conventional biofuels production, advanced biofuels production and cellulosic biofuels ...
(Date:8/7/2018)... BOSTON and SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 ... ... communications and collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. ... cloud delivering a scalable and secure, quality voice solution that is far superior to ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... to pharmaceutical and biotech companies, today announced that Mark Jara, principal of the ... people in the life sciences industry. Individuals named to PharmaVOICE 100 are leaders ...
Breaking Biology News(10 mins):